Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

B K Olesen

Showing results (1-10 of 5) with videos related to

Pageof 1
Sort By:
Ugeskrift for Laeger|February 10, 1986
[The antineoplastic effect of interferon]B K Olesen, P Ernst
Journal of Interferon Research|January 1, 1984
Effect of recombinant alpha interferon on NK and ADCC function in lung cancer patients: results from a phase II trialP Hokland, M Hokland, B K Olesen, et al.
European Journal of Cancer & Clinical Oncology|July 1, 1987
Recombinant interferon A (IFL-rA) therapy of small cell and squamous cell carcinoma of the lung. A phase II studyB K Olesen, P Ernst, M H Nissen, et al.
Clinical and Experimental Immunology|February 1, 1985
Enhanced expression in vivo of HLA-ABC antigens and beta 2-microglobulin on human lymphoid cells induced by human interferon-alpha in patients with lung cancer. Enhanced expression of class I major histocompatibility antigens prior to treatmentM H Nissen, T Plesner, J K Larsen, et al.
Clinical and Experimental Immunology|September 1, 1987
Alpha-interferon induces enhanced expression of HLA-ABC antigens and beta-2-microglobulin in vivo and in vitro in various subsets of human lymphoid cellsM H Nissen, J K Larsen, T Plesner, et al.
Pageof 1

Showing results (1-10 of 5) with videos related to

Sort By:
Pageof 1
Ugeskrift for Laeger|February 10, 1986
[The antineoplastic effect of interferon]B K Olesen, P Ernst
Journal of Interferon Research|January 1, 1984
Effect of recombinant alpha interferon on NK and ADCC function in lung cancer patients: results from a phase II trialP Hokland, M Hokland, B K Olesen, et al.
European Journal of Cancer & Clinical Oncology|July 1, 1987
Recombinant interferon A (IFL-rA) therapy of small cell and squamous cell carcinoma of the lung. A phase II studyB K Olesen, P Ernst, M H Nissen, et al.
Clinical and Experimental Immunology|February 1, 1985
Enhanced expression in vivo of HLA-ABC antigens and beta 2-microglobulin on human lymphoid cells induced by human interferon-alpha in patients with lung cancer. Enhanced expression of class I major histocompatibility antigens prior to treatmentM H Nissen, T Plesner, J K Larsen, et al.
Clinical and Experimental Immunology|September 1, 1987
Alpha-interferon induces enhanced expression of HLA-ABC antigens and beta-2-microglobulin in vivo and in vitro in various subsets of human lymphoid cellsM H Nissen, J K Larsen, T Plesner, et al.
Pageof 1